BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $21.87 million. The enterprise value is $16.14 million.

Market Cap	21.87M
Enterprise Value	16.14M

Important Dates

The next estimated earnings date is Tuesday, June 24, 2025, after market close.

Earnings Date	Jun 24, 2025
Ex-Dividend Date	n/a

Share Statistics

BCTX has 6.12 million shares outstanding. The number of shares has increased by 58.67% in one year.

Current Share Class	6.12M
Shares Outstanding	6.12M
Shares Change (YoY)	+58.67%
Shares Change (QoQ)	+52.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.78
P/TBV Ratio	6.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37

Current Ratio	1.37
Quick Ratio	1.37
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-158.14%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-661.06%
Revenue Per Employee	n/a
Profits Per Employee	-$724,500
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.44% in the last 52 weeks. The beta is 1.72, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.72
52-Week Price Change	-82.44%
50-Day Moving Average	3.78
200-Day Moving Average	7.55
Relative Strength Index (RSI)	51.24
Average Volume (20 Days)	749,166

Short Selling Information

The latest short interest is 517,532, so 8.46% of the outstanding shares have been sold short.

Short Interest	517,532
Short Previous Month	169,685
Short % of Shares Out	8.46%
Short % of Float	10.12%
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.32M
Pretax Income	-6.04M
Net Income	-11.59M
EBITDA	-27.19M
EBIT	-27.32M
Earnings Per Share (EPS)	-$6.92

Full Income Statement

Balance Sheet

The company has $5.01 million in cash and n/a in debt, giving a net cash position of $5.01 million or $0.82 per share.

Cash & Cash Equivalents	5.01M
Total Debt	n/a
Net Cash	5.01M
Net Cash Per Share	$0.82
Equity (Book Value)	3.23M
Book Value Per Share	1.22
Working Capital	1.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.99 million and capital expenditures -$456,801, giving a free cash flow of -$22.45 million.

Operating Cash Flow	-21.99M
Capital Expenditures	-456,801
Free Cash Flow	-22.45M
FCF Per Share	-$3.67

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.67%
Shareholder Yield	-58.67%
Earnings Yield	-53.00%
FCF Yield	-102.65%

Analyst Forecast

The average price target for BCTX is $32.00, which is 806.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	806.52%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a